SCHEMBL3836709

SCHEMBL3836709

Cc1cccc2c(N3CCC(C)CC3)c(S(=O)(=O)c3ccc(F)c(Cl)c3)cnc12

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 11/20 0.60
CES2 O00748 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 2/20 0.41
HTR1A P08908 1/20 0.41
HTR2A P28223 1/20 0.41
HTR7 P34969 1/20 0.41
HTR6 P50406 1/20 0.41
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
THRB P10828 2/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3832691 0.93 GRM5 (0.61) GRM5CES2SMN1; SMN2POLBHTR1A
SCHEMBL3831529 0.93 GRM5 (0.60) GRM5CES2SMN1; SMN2HTR1AHTR2A
SCHEMBL3834589 0.90 GRM5 (0.58) GRM5CES2POLBLMNAMAPT
SCHEMBL3830976 0.89 GRM5 (0.59) GRM5CES2SMN1; SMN2POLBHTR1A
SCHEMBL3834912 0.89 GRM5 (0.67) GRM5CES2SMN1; SMN2POLBHTR1A
SCHEMBL3836529 0.88 GRM5 (0.55) GRM5CES2POLBHTR1AHTR2A
SCHEMBL3836170 0.87 GRM5 (0.69) GRM5CES2SMN1; SMN2POLBHTR1A
SCHEMBL3835262 0.87 GRM5 (0.72) GRM5CES2HTR2AHTR6
SCHEMBL3832742 0.85 GRM5 (0.62) GRM5CES2SMN1; SMN2LMNAALDH1A1
SCHEMBL3834028 0.84 GRM5 (0.58) GRM5CES2LMNAMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1962849-B1 QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS RICHTER GEDEON NYRT (HU) 2009-09-30 EP claimed